Long-Term Effects of Extended-Release Mixed Amphetamine Salts Treatment of Attention- Deficit/Hyperactivity Disorder on Growth
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim of this study was to examine the long-term effects of extended-release mixed amphetamine salts (MAS-XR) with 10-30-mg doses on the growth of children being treated for attention-deficit/hyperactivity disorder (ADHD). METHODS: Long-term growth data were collected from 568 children, 6-12 years of age, enrolled in a multicenter, open-label study of the safety of MAS-XR for the treatment of ADHD symptoms over the course of 6-30 months. RESULTS: Children taking MAS-XR grew less than expected, based on the norms provided by the Centers for Disease Control (CDC). The losses in expected weight and body mass index (BMI) were greatest for the heaviest children, and the losses in expected height were greatest for the tallest children. For weight, height, and BMI, we found that nearly all of the growth deficits occurred in year one. For each of these growth parameters, the loss in expected growth was not significant in the second year of treatment. CONCLUSIONS: Our results suggest that treatment with MAS-XR can lead to reductions in expected height and weight that are not fully rectified over the course of treatment, although they did show attenuation with treatment over time. Although this does not eliminate the need for clinicians to monitor growth, as they should for all stimulant formulations, it suggests that deficits in growth are not likely to be a clinical concern for most children treated with MAS-XR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MTA Cooperative Group (2004) · Pediatrics · doi:10.1542/peds.113.4.754 · Cited by 589
Wolraich, M. L., Greenhill, L. L., Pelham, W., Swanson, J., Wilens, T., Palumbo, D., Atkins, M., McBurnett, K., Bukstein, O., August, G., et al. (2001) · Pediatrics · doi:10.1542/peds.108.4.883 · Cited by 502
Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
SPENCER, T. J., BIEDERMAN, J., HARDING, M., O'DONNELL, D., FARAONE, S. V., & WILENS, T. E. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199611000-00014 · Cited by 238
Self-citationBiederman, J., Lopez, F. A., Boellner, S. W., & Chandler, M. C. (2002) · Pediatrics · doi:10.1542/peds.110.2.258 · Cited by 180 · cited 13×
“…found no deficits in age-adjusted height or weight in the ADHD girls and also found no effects of psychotropic treatment on height or weight advent of long-acting versions of methyl-phenidate (Greenhill et al. 2002; Wolraich et al. 2001) and mixed amphetamine salts (MAS) (Biederman et al. 2002).”
InfluentialSelf-citationBiederman, J., Faraone, S. V., Monuteaux, M. C., Plunkett, E. A., Gifford, J., & Spencer, T. (2003) · Pediatrics · doi:10.1542/peds.111.5.1010 · Cited by 133 · cited 1×
“Using similar methodology in a different sample, Biederman et al. (2003) studied 124 female ADHD children and 116 female controls .”
Self-citationSlowing of growth in height and weight on stimulants: A characteristic pattern
Poulton, A., & Cowell, C. (2003) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2003.00107.x · Cited by 132 · cited 3×
“Thus, our”
Growth rebound after termination of stimulant drugs
Safer, D. J., Allen, R. P., & Barr, E. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80720-7 · Cited by 123 · cited 1×
“Safer and Allen (1973), Safer et al. (1972, 1975 ), Loney et al. (1981), Poulton and Mattes and Gittelman (1983) each concluded that stimulant treatment in children with ADHD led to statistically significant suppression of growth in weight and height.”
Cited by
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Attention-deficit hyperactivity disorder
Biederman, J., & Faraone, S. V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66915-2 · Cited by 1,463
Self-citationAttention‐Deficit‐Hyperactivity Disorder: An Update
Dopheide, J. A., & Pliszka, S. R. (2009) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.656 · Cited by 645
Sharma, A., & Couture, J. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028013510699 · Cited by 516
Endocrine and Metabolic Adverse Effects of Psychotropic Medications in Children and Adolescents
CORRELL, C. U., & CARLSON, H. E. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000220851.94392.30 · Cited by 403
Metadata
- Authors
- Faraone, S. V., Biederman, J., Monuteaux, M., & Spencer, T.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2005-04
- Volume
- 15
- Issue
- 2
- Pages
- 191-202
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2008409978
- Cited by
- 80
- References
- 7
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-Term Effects of Extended-Release Mixed Amphetamine Salts Treatment of Attention- Deficit/Hyperactivity Disorder on Growth. https://app.cochat.ai/papers/10.1089/cap.2005.15.191
- The paper
- Faraone, S. V., Biederman, J., Monuteaux, M., & Spencer, T. (2005). Long-Term Effects of Extended-Release Mixed Amphetamine Salts Treatment of Attention- Deficit/Hyperactivity Disorder on Growth. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2005.15.191
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.